Mounjaro vs. Zepbound: Understanding the Difference

What actually separates Mounjaro from Zepbound?

Both medicines contain tirzepatide, and both are made by Eli Lilly. That is where the similarity ends on the label. Mounjaro and Zepbound are approved for different conditions, approved to different maximum doses for those different purposes, and carry different limitations on use. 1 2

	Mounjaro	Zepbound
Active ingredient	Tirzepatide	Tirzepatide
Manufacturer	Eli Lilly	Eli Lilly
What it is approved to treat	Blood sugar control in type 2 diabetes, alongside diet and exercise; reducing major cardiovascular events in adults with type 2 diabetes at high cardiovascular risk	Long-term weight reduction and maintenance in adults with obesity, or overweight plus a weight-related condition, alongside a reduced-calorie diet and more physical activity; moderate-to-severe obstructive sleep apnea in adults with obesity
Approved for diabetes?	Yes	No
Approved for weight management on its own?	No	Yes
Approved for pediatric patients?	Yes — 10 years and older, for glycemic control	No
Approved maximum dose	15 mg once weekly (adults); 10 mg once weekly (pediatric)	15 mg once weekly
Forms available	Single-dose pen or vial; multi-dose vial or KwikPen	Single-dose pen or vial; multi-dose vial or KwikPen

A clinician still decides which product, if either, fits your health history and sets your actual starting dose and any dose changes — this table describes what each label approves, not instructions for you to follow on your own. 1 2

Because the two products share an active ingredient, general drug-reference sites often describe Mounjaro and Zepbound under a single "tirzepatide injection" entry — worth knowing if a search for one brand turns up information about both. 3

What is Mounjaro approved to treat?

Mounjaro's label covers two uses, both tied to type 2 diabetes: improving blood sugar control alongside diet and exercise in adults and in pediatric patients 10 years of age and older, and reducing the risk of major adverse cardiovascular events — cardiovascular death, non-fatal heart attack, or non-fatal stroke — in adults with type 2 diabetes who are at high risk for those events. 1

Weight loss is a documented effect of the medicine, but it is not a listed indication. The label does not authorize prescribing Mounjaro to someone whose only goal is weight management and who does not have type 2 diabetes. 1

What is Zepbound approved to treat?

Zepbound is not approved to treat diabetes. Its label covers two separate uses: reducing excess body weight and maintaining that weight reduction long term in adults with obesity, or in adults with overweight plus at least one weight-related condition, always alongside a reduced-calorie diet and increased physical activity; and treating moderate-to-severe obstructive sleep apnea in adults with obesity. Neither approval extends to children or adolescents. 2

The label also states that combining Zepbound with another tirzepatide-containing product, or with any other GLP-1 receptor agonist, is not recommended — a detail worth raising if a provider suggests layering treatments. 2

Why do people talk about using Mounjaro for weight loss?

Because it is the same molecule, some clinicians prescribe Mounjaro for weight management in people who do not have diabetes. This is legal: once the FDA approves a drug, a clinician may prescribe it for a use the label does not list when they judge it medically appropriate for that patient. It does mean the FDA has not specifically reviewed Mounjaro — as opposed to Zepbound — for that use, and the decision rests on your clinician's judgment, not a marketing claim. 4

If cost or coverage is part of why a provider is offering you one product instead of the other, ask directly why, and confirm the answer with your own insurer rather than assuming. Our GLP-1 cost guide covers how to compare total cost across a treatment plan.

What about counterfeit or compounded products sold under either name?

The FDA has documented adverse events tied to compounded versions of tirzepatide made outside the approved manufacturing process — more than 730 reports as of the agency's most recent count — alongside warnings about counterfeit products circulating for other GLP-1 medicines. Neither a compounded product nor a counterfeit one has gone through the agency's review for safety, effectiveness, and quality, and either can contain the wrong ingredient, the wrong amount, or none at all. 5

Ask any pharmacy — online or in person — to confirm it is state-licensed and to identify exactly what it is dispensing before you pay. Our guide to compounded versus brand-name GLP-1 medicines has a longer checklist for that conversation.

What should you ask before choosing between them?

Bring these questions to the appointment rather than arriving with a brand name already decided:

• Which product are you prescribing, and is it FDA-approved for my situation?
• If it is Mounjaro and I do not have diabetes, why is that the right choice for me?
• What would make you recommend the other product instead?
• Where is this being dispensed, and how do I confirm the pharmacy's license?

Our broader GLP-1 guide walks through the rest of that first conversation, and semaglutide versus tirzepatide covers the separate question of comparing tirzepatide to a different active ingredient. If you're weighing a similar brand pair built on semaglutide instead, our Ozempic versus Wegovy comparison walks through that split the same way.

Common questions

Can I just ask for Mounjaro instead of Zepbound to save money?

Ask your clinician and your insurer directly rather than assuming. Coverage often depends on the diagnosis code attached to the prescription, among other factors specific to your plan, so a general answer would not be accurate for your situation.

Is Zepbound simply a higher dose of Mounjaro?

No. The two labels list different approved maximum doses for different purposes and different approved uses; the difference is not just "more of the same medicine." Only a clinician working from your prescription can explain what dose you have been prescribed and why. 1 2

Does either of these treat menopause symptoms?

No. Neither Mounjaro nor Zepbound is approved to treat menopause symptoms, and weight treatment is a separate conversation from menopause care even when both come up in the same appointment.